Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases.
- Sector(s): Healthcare
- Industry: Biotechnology
- Full Time Employees: 36
- Incorporated in 2014
- Headquartered in Irvine, California
- https://reneopharma.com
Reneo Pharmaceuticals priced 6.25 share IPO at $15.00 per share, at the low end of the $15-17 expected range
No comments:
Post a Comment